IRONWOOD PHARMACEUTICALS INC (IRWD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q1 '10: 8.8M Q2 '10: 9.2M Q3 '10: 9.1M Q4 '10: 16.8M Q1 '11: 10.2M Q2 '11: 11.3M Q3 '11: 12.2M Q4 '11: 32.2M Q1 '12: 12.2M Q2 '12: 14.6M Q3 '12: 96.4M Q4 '12: 27M Q1 '13: 3.3M Q2 '13: 9.7M Q3 '13: 4.9M Q4 '13: 5M Q1 '14: 14.6M Q2 '14: 6.8M Q3 '14: 16.9M Q4 '14: 38.1M Q1 '15: 28.9M Q2 '15: 27.7M Q3 '15: 39.6M Q4 '15: 53.3M Q1 '16: 66M Q2 '16: 54.4M Q3 '16: 66.1M Q4 '16: 87.5M Q1 '17: 52.2M Q2 '17: 65.1M Q3 '17: 86.8M Q4 '17: 94.2M Q1 '18: 69.2M Q2 '18: 81.1M Q3 '18: 65.7M Q4 '18: 130.7M Q1 '19: 68.7M Q2 '19: 102.2M Q3 '19: 131.2M Q4 '19: 126.3M Q1 '20: 79.9M Q2 '20: 89.4M Q3 '20: 103.5M Q4 '20: 116.7M Q1 '21: 88.8M Q2 '21: 104M Q3 '21: 103.7M Q4 '21: 117.1M Q1 '22: 97.5M Q2 '22: 97.2M Q3 '22: 108.6M Q4 '22: 107.2M Q1 '23: 104.1M Q2 '23: 107.4M Q3 '23: 113.7M Q4 '23: 117.6M Q1 '24: 74.9M Q2 '24: 94.4M Q3 '24: 91.6M Q4 '24: 90.5M Q1 '25: 41.1M Q2 '25: 85.2M Q3 '25: 122.1M Q4 '25: 47.7M Q1 '26: 106.5M Q2 '26: 113M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q1 '17: 51.6M Q2 '17: 61.6M Q3 '17: 80.7M Q4 '17: 85.2M Q1 '18: 66.5M Q2 '18: 77M Q3 '18: 61.1M Q4 '18: 109.2M Q1 '19: 67.7M Q2 '19: 90.9M Q3 '19: 130.7M Q4 '19: 115.3M Q1 '20: 77.7M Q2 '20: 89.4M Q3 '20: 103.5M Q4 '20: 115.8M Q2 '17 Q4 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-1.2B -800M -400M 0 400M 800M 1.2B Q1 '10: -14.5M Q2 '10: -17.3M Q3 '10: -16.2M Q4 '10: -12.8M Q1 '11: -18.5M Q2 '11: -19M Q3 '11: -21.6M Q4 '11: -7M Q1 '12: -35.6M Q2 '12: -40.8M Q3 '12: 47.6M Q4 '12: -43.9M Q1 '13: -88.8M Q2 '13: -59.9M Q3 '13: -56.6M Q4 '13: -46.7M Q1 '14: -44.4M Q2 '14: -55.1M Q3 '14: -36.7M Q4 '14: -33.1M Q1 '15: -28.1M Q2 '15: -42M Q3 '15: -26.2M Q4 '15: -5.8M Q1 '16: -2M Q2 '16: -15.3M Q3 '16: -28.3M Q4 '16: -6.3M Q1 '17: -39.7M Q2 '17: -41M Q3 '17: -19.4M Q4 '17: 84.8M Q1 '18: -35.9M Q2 '18: -14.7M Q3 '18: -146.6M Q4 '18: 46.4M Q1 '19: -16.9M Q2 '19: 21.6M Q3 '19: 65.9M Q4 '19: 49.6M Q1 '20: 13.2M Q2 '20: 32.7M Q3 '20: 45.6M Q4 '20: 51.4M Q1 '21: 45.4M Q2 '21: 65.1M Q3 '21: 65.2M Q4 '21: 56.6M Q1 '22: 57.8M Q2 '22: 55.7M Q3 '22: 68.5M Q4 '22: 68.4M Q1 '23: 60.1M Q2 '23: -1.1B Q3 '23: 40M Q4 '23: 37.6M Q1 '24: 11M Q2 '24: 25M Q3 '24: 25.6M Q4 '24: 31.5M Q1 '25: -29.1M Q2 '25: 45.3M Q3 '25: 75.5M Q4 '25: 6.8M Q1 '26: 72.6M Q2 '26: 79.3M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-1.2B -800M -400M 0 400M 800M 1.2B Q1 '10: -16.3M Q2 '10: -17.1M Q3 '10: -6.7M Q4 '10: -11.7M Q1 '11: -18.4M Q2 '11: -18.8M Q3 '11: -20.6M Q4 '11: -7M Q1 '12: -35.6M Q2 '12: -40.8M Q3 '12: 47.6M Q4 '12: -43.9M Q1 '13: -93.9M Q2 '13: -65.1M Q3 '13: -61.8M Q4 '13: -52M Q1 '14: -49.6M Q2 '14: -60.4M Q3 '14: -42M Q4 '14: -37.6M Q1 '15: -33.2M Q2 '15: -48M Q3 '15: -47.4M Q4 '15: -14M Q1 '16: -13.3M Q2 '16: -21.7M Q3 '16: -33.2M Q4 '16: -13.5M Q1 '17: -52.5M Q2 '17: -44.2M Q3 '17: -32.3M Q4 '17: 12.1M Q1 '18: -43.1M Q2 '18: -49.4M Q3 '18: -174.4M Q4 '18: -15.5M Q1 '19: -59.3M Q2 '19: 12.3M Q3 '19: 20.6M Q4 '19: 47.9M Q1 '20: 3.3M Q2 '20: 25.2M Q3 '20: 34.4M Q4 '20: 43.2M Q1 '21: 39.9M Q2 '21: 391.3M Q3 '21: 55.8M Q4 '21: 41.4M Q1 '22: 38.8M Q2 '22: 37.1M Q3 '22: 50.3M Q4 '22: 48.9M Q1 '23: 45.7M Q2 '23: -1.1B Q3 '23: 15.3M Q4 '23: -1.1M Q1 '24: -4.2M Q2 '24: -860K Q3 '24: 3.6M Q4 '24: 2.3M Q1 '25: -37.4M Q2 '25: 23.6M Q3 '25: 40.1M Q4 '25: -2.3M Q1 '26: 40.8M Q2 '26: 51.3M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

-16M -8M 0 8M 16M 24M Q1 '13: 1.2M Q2 '13: 3.4M Q3 '13: 2M Q4 '13: 533K Q1 '14: 1.9M Q2 '14: 10.5M Q3 '14: -8.9M Q4 '14: 1.7M Q1 '15: 12K Q2 '15: 8.2M Q3 '15: -8.2M Q4 '15: 0 Q1 '17: 531K Q2 '17: 3.5M Q3 '17: 6.1M Q4 '17: 9M Q1 '18: 2.6M Q2 '18: 4.1M Q3 '18: 4.6M Q4 '18: 21.5M Q1 '19: 1M Q2 '19: 11.3M Q3 '19: 506K Q4 '19: 11M Q1 '20: 2.2M Q2 '20: 0 Q3 '20: 0 Q4 '20: 897K Q4 '13 Q4 '14 Q4 '15 Q4 '17 Q4 '18 Q4 '19 Q4 '20

Operating Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '10: -22.8M Q4 '10: -646K Q1 '11: -23.9M Q2 '11: -18.2M Q3 '11: -25.4M Q4 '11: -7.7M Q1 '12: -43.1M Q2 '12: -43.1M Q3 '12: 39M Q4 '12: -22.5M Q1 '13: -93.2M Q2 '13: -80.1M Q3 '13: -58M Q4 '13: -42.1M Q1 '14: -57.9M Q2 '14: -36.2M Q3 '14: -38.7M Q4 '14: -22.8M Q1 '15: -35.8M Q2 '15: -25.6M Q3 '15: -26.2M Q4 '15: -19.4M Q1 '16: 161K Q2 '16: -6.3M Q3 '16: -645K Q4 '16: -19.2M Q1 '17: -27.8M Q2 '17: -32.5M Q3 '17: -31.2M Q4 '17: -9.2M Q1 '18: -30.9M Q2 '18: -22.7M Q3 '18: -26.6M Q4 '18: 9.3M Q1 '19: -42.4M Q2 '19: -9.2M Q3 '19: 34.8M Q4 '19: 27.6M Q1 '20: 43.6M Q2 '20: 20.1M Q3 '20: 53.6M Q4 '20: 51.5M Q1 '21: 73.7M Q2 '21: 48.6M Q3 '21: 75.1M Q4 '21: 64.6M Q1 '22: 64.1M Q2 '22: 61.4M Q3 '22: 69.1M Q4 '22: 79.2M Q1 '23: 80.2M Q2 '23: 35M Q3 '23: 32.5M Q4 '23: 35.8M Q1 '24: 45M Q2 '24: 33.5M Q3 '24: 9.9M Q4 '24: 15.2M Q1 '25: 20M Q2 '25: -15.1M Q3 '25: 47.6M Q4 '25: 74.6M Q1 '26: 5.1M Q2 '26: 58.3M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '10: -29.3M Q4 '10: -2.8M Q1 '11: -27.4M Q2 '11: -20.2M Q3 '11: -26M Q4 '11: -11.3M Q1 '12: -47.7M Q2 '12: -45.5M Q3 '12: 35.4M Q4 '12: -25.8M Q1 '13: -96.1M Q2 '13: -82.1M Q3 '13: -58.9M Q4 '13: -45.8M Q1 '14: -59.2M Q2 '14: -36.9M Q3 '14: -39.2M Q4 '14: -23.8M Q1 '15: -37.8M Q2 '15: -26.4M Q3 '15: -26.6M Q4 '15: -20.2M Q1 '16: -847K Q2 '16: -6.9M Q3 '16: -2M Q4 '16: -20.4M Q1 '17: -28.9M Q2 '17: -33.2M Q3 '17: -32.7M Q1 '18: -32.4M Q2 '18: -22.8M Q3 '18: -27.9M Q4 '18: 9M Q1 '19: -45.6M Q2 '19: -11M Q3 '19: 31.7M Q4 '19: 24.9M Q1 '20: 42.2M Q2 '20: 19.7M Q3 '20: 53.6M Q4 '20: 51.5M Q4 '21: 64.4M Q1 '22: 64.1M Q2 '22: 61.3M Q3 '22: 69M Q1 '23: 80.2M Q2 '23: 35M Q3 '23: 32.4M Q4 '23: 35.6M Q1 '24: 44.9M Q2 '24: 33.4M Q3 '24: 9.9M Q4 '24: 15.2M Q1 '25: 19.9M Q2 '25: -15.1M Q3 '25: 47.6M Q4 '25: 74.6M Q3 '10 Q3 '12 Q3 '14 Q3 '16 Q4 '18 Q4 '20 Q4 '23 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q2 '10: 97.6M Q3 '10: 97.9M Q1 '11: 99.1M Q2 '11: 99.7M Q3 '11: 100.2M Q1 '12: 103.8M Q2 '12: 107.1M Q3 '12: 114.3M Q3 '13: 120.8M Q1 '19: 155K Q2 '19: 155.8K Q3 '19: 156.8K Q1 '20: 160M Q2 '20: 159.9M Q3 '20: 160.3M Q1 '21: 162.3M Q2 '21: 163.5M Q3 '21: 165.2M Q1 '22: 189.5M Q2 '22: 184.9M Q3 '22: 184.5M Q1 '23: 186.7M Q2 '23: 155.4M Q3 '23: 186.9M Q1 '24: 157.7M Q2 '24: 159M Q3 '24: 160.2M Q1 '25: 161M Q2 '25: 176.8M Q3 '25: 177.8M Q1 '26: 166.7M Q2 '26: 167.2M Q2 '11 Q3 '12 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '10: -0.63 Q1 '11: -0.57 Q2 '11: -0.58 Q3 '11: -0.71 Q4 '11: -0.66 Q1 '12: -0.81 Q2 '12: -1.00 Q3 '12: -0.37 Q4 '12: -0.71 Q1 '13: -1.24 Q2 '13: -1.43 Q3 '13: -2.36 Q4 '13: -2.38 Q1 '14: -1.89 Q2 '14: -1.76 Q3 '14: -1.55 Q4 '14: -1.39 Q1 '15: -1.25 Q2 '15: -1.15 Q3 '15: -1.18 Q4 '15: -1.00 Q1 '16: -0.85 Q2 '16: -0.66 Q3 '16: -0.56 Q4 '16: -0.56 Q1 '17: -0.83 Q2 '17: -0.98 Q3 '17: -0.97 Q4 '17: -0.80 Q1 '18: -0.73 Q2 '18: -0.75 Q3 '18: -1.67 Q4 '18: -1.85 Q3 '20: 0.69 Q4 '20: 0.66 Q1 '21: 0.89 Q2 '21: 3.12 Q3 '21: 3.25 Q4 '21: 3.23 Q1 '22: 3.19 Q2 '22: 1.01 Q3 '22: 0.95 Q4 '22: 0.97 Q1 '23: 1.01 Q2 '23: -6.04 Q3 '23: -6.23 Q4 '23: -6.51 Q1 '24: -6.79 Q2 '24: 0.04 Q3 '24: -0.03 Q4 '24: -0.01 Q1 '25: -0.21 Q2 '25: -0.06 Q3 '25: 0.15 Q4 '25: 0.13 Q1 '26: 0.60 Q2 '26: 0.77 Q4 '10 Q4 '12 Q4 '14 Q4 '16 Q4 '18 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.